GAMBARAN PEMERIKSAAN ANTI STREPTOLISIN O (ASTO) PADA PENDERITA PENYAKIT JANTUNG DI RSUD KOTA KENDARI
Abstract
ABSTRAK
Anti streptolisin O (Asto) merupakan antibodi yang dapat menghasilkan berbagai produk ekstraseluler yang mampu merangsang antigen. Antibodi ini tidak merusak kuman dan tidak mempunyai dampak perlindungan, tetapi adanya antibodi pada serum menunjukkan bahwa di dalam tubuh terinfeksi Steptococcus yang aktif. Tujuan penelitian ini adalah untuk mengetahui adanya anti streptolisin O pada pasien penyakit jantung di Rumah Sakit Umum Daerah Kota Kendari. Sampe Pasien penyakit jantung sebanyak 30 yang diambil dengan tekhnik acidental sampling dan dilakukan pemeriksaan menggunakan Metode slide aglutinasi. Berdasarkan penelitian yang telah dilakukan menunjukkan hasil dari 30 sampel terdapat 3 (10%) sampel positif anti streptolisin O (ASTO) yaitu ditandai dengan terjadinya aglutinasi dan 27 (97%) negatif anti streptolisin O (ASTO) dilihat pada sampel pasien tidak terjadi aglutinasi.
Kata Kunci : Anti Streptolisin O, Penyakit Jantung
ABSTRACT
Anti Streptolysin O (ASTO) is an antibody that can produce various extracellular products that can stimulate antigen. These antibodies do not damage germs and have no protective effect, but the presence of serum antibodies indicates that in the body is infected with active Steptococcus. The purpose of this study was to determine the presence of anti streptolysin O in patients by heart disease in Kendari District General Hospital. Patient samples of heart disease as many as 30 were taken with accidental sampling technique and examined using agglutination slide method. Based on the research that has been done shows that there are 3 (10%) positive samples of anti streptolysin O (ASTO) that is characterized by agglutination and 27 (97%) negative anti streptolysin O (ASTO) seen in patient samples no agglutination occurs.
Keywords: Anti Streptolysin O, Heart Disease, Aglutination
Additional Files
Published
Issue
Section
License
Authors who publish on JAKK can share their research in a number of ways. JAKK does not impose an embargo on published journals, meaning that researchers can access it openly after the article is published. Researchers who have subscribed to access to articles can also share.
JAKK already uses the Open Journal System (OJS) thereby enabling the final version of all published research articles to be placed in any digital archive immediately after publication. JAKK can automatically make feeds of open access articles available to any repository that wishes to receive them.
Authors who publish with this journal agree to the following terms:
* Authors retain copyright and grant the journal right of first publication, with licensed under a Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
* Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
* Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
2.jpg)
